Basilea announces U.S. FDA Orphan Drug Designation granted to lisavanbulin for the treatment of malignant glioma

Liz Kane
Impactful Strategy

Stacey Gandler
Brand Nourishment

Paul Theisen
Patient Acquisition

Bud Bilanich
Success Coach

Matthew Durham
Omnidynamic Marketing

Pat Purcell
Meeting Engagement

Amy Giles
Increasing Engagement

Suma Ramadas, PhD
Medical Affairs

Joey Cohen
Medication Adherence

Matt Turner
Patient Affordability

Brenda Snow
Authentic Patient Voice

Daniel Sontupe
Market Access

David Linetsky
Point-of-Care Marketing

Frank Burrell
Scientific Storytelling